R. Sinha

发表

Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead

Anna C. Salzberg, Y. Rojanasakul, M. Kirsch‐Volders, 2015, Carcinogenesis.

Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death.

William H. Bisson, Annamaria Colacci, Rabindra Roy, 2015, Carcinogenesis.

Fyn kinase regulates type II PtdIns 4-kinases in RBL 2H3 cells

R. Sinha, Naveen Bojjireddy, G. Subrahmanyam, 2014, Molecular and Cellular Biochemistry.

Piperine inhibits type II phosphatidylinositol 4-kinases: a key component in phosphoinositides turnover

R. Sinha, Naveen Bojjireddy, G. Subrahmanyam, 2014, Molecular and Cellular Biochemistry.

The TLR4‐PAR1 Axis Regulates Bone Marrow Mesenchymal Stromal Cell Survival and Therapeutic Capacity in Experimental Bacterial Pneumonia

V. Nizet, J. Griffin, M. Matthay, 2018, Stem cells.

Type II PtdIns 4-kinase β associates with CD4–p56lck complex and is involved in CD4 receptor signaling

Deepak Kanojia, R. Sinha, Naveen Bojjireddy, 2014, Molecular and Cellular Biochemistry.

PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke.

José A Fernández, J. Griffin, B. Zlokovic, 2018, Blood.

Type II phosphatidylinositol 4-kinases interact with FcεRIγ subunit in RBL-2H3 cells

R. Sinha, Naveen Bojjireddy, G. Subrahmanyam, 2014, Molecular and Cellular Biochemistry.

SCH79797 improves outcomes in experimental bacterial pneumonia by boosting neutrophil killing and direct antibiotic activity

V. Nizet, K. Pogliano, J. Pogliano, 2018, The Journal of antimicrobial chemotherapy.

Activated Protein C Ameliorates Chronic Graft-Versus-Host Disease by PAR1-dependent Biased Cell Signaling on T-cells.

José A Fernández, J. Griffin, D. Nemazee, 2019, Blood.

Type II phosphatidylinositol 4-kinase associates with TCR-CD3 chain in Jurkat cells

R. Sinha, G. Subrahmanyam, Rupa Srivastava, 2006 .

Type II phosphatidylinositol 4-kinase β is an integral signaling component of early T cell activation mechanisms.

R. Sinha, A. Ratheesh, S. Chiplunkar, 2013, Biochimie.

A type II phosphatidylinositol 4-kinase associates with T cell receptor zeta chain in Con A stimulated splenic lymphocytes through tyrosyl phosphorylation-dependent mechanisms.

A. Fernandis, R. Sinha, G. Subrahmanyam, 2005, Molecular immunology.

Fyn kinase regulates type II PtdIns 4-kinases in RBL 2H3 cells

R. Sinha, Naveen Bojjireddy, G. Subrahmanyam, 2014, Molecular and Cellular Biochemistry.

Piperine inhibits type II phosphatidylinositol 4-kinases: a key component in phosphoinositides turnover

R. Sinha, Naveen Bojjireddy, G. Subrahmanyam, 2014, Molecular and Cellular Biochemistry.

Dipole-induced chiral smectic-C phase in a eutectic mixture of cholesterol esters

R. Sinha, S. Basu, U. Das, 2005 .

Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice.

J. Griffin, B. Zlokovic, Yaoming Wang, 2013, Blood cells, molecules & diseases.

Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead

Anna C. Salzberg, Y. Rojanasakul, M. Kirsch‐Volders, 2015, Carcinogenesis.

Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.

J. Griffin, R. Sinha, E. Bouwens, 2012, Blood.

Key Points * R 41 Q and R 46 Q point mutations in PAR 1 in mice enabled studies of APC ’ s in vivo mechanism of action in lethal sepsis and ischemic stroke

José A Fernández, J. Griffin, B. Zlokovic, 2018 .

Epigallocatechin gallate (EGCG) inhibits type II phosphatidylinositol 4-kinases: a key component in pathways of phosphoinositide turnover.

R. Sinha, A. Datta, Naveen Bojjireddy, 2011, Archives of biochemistry and biophysics.

Apolipoprotein E Receptor 2 Mediates Activated Protein C–Induced Endothelial Akt Activation and Endothelial Barrier Stabilization

José A Fernández, J. Griffin, Xia V. Yang, 2016, Arteriosclerosis, thrombosis, and vascular biology.

caused by noncanonical cleavage at Arg46 Biased agonism of protease-activated receptor 1 by activated protein C

R. Sinha, E. Bouwens, L. Burnier, 2013 .

Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.

O. McCarty, M. Cohen, J. Griffin, 2016, Blood.

Type II phosphatidylinositol 4-kinase beta associates with TCR-CD3 zeta chain in Jurkat cells.

R. Sinha, G. Subrahmanyam, Rupa Srivastava, 2006, Molecular immunology.

Type II phosphatidylinositol 4-kinases interact with FcεRIγ subunit in RBL-2H3 cells

R. Sinha, Naveen Bojjireddy, G. Subrahmanyam, 2014, Molecular and Cellular Biochemistry.

Sanguinarine suppresses IgE induced inflammatory responses through inhibition of type II PtdIns 4-kinase(s).

R. Sinha, D. Panda, Naveen Bojjireddy, 2013, Archives of biochemistry and biophysics.

Type II phosphatidylinositol 4-kinase(s) in cell signaling cascades.

R. Sinha, G. Subrahmanyam, 2007, Indian journal of biochemistry & biophysics.

Activated protein C light chain provides an extended binding surface for its anticoagulant cofactor, protein S.

José A Fernández, M. Sanner, J. Griffin, 2017, Blood advances.

Type II PtdIns 4-kinase β associates with CD4–p56lck complex and is involved in CD4 receptor signaling

Deepak Kanojia, R. Sinha, Naveen Bojjireddy, 2014, Molecular and Cellular Biochemistry.

Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead

William H. Bisson, Anna C. Salzberg, Y. Rojanasakul, 2015, Carcinogenesis.

Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice.

J. Griffin, B. Zlokovic, Yaoming Wang, 2013, Blood cells, molecules & diseases.